Please provide your email address to receive an email when new articles are posted on . FORT WORTH, Texas — The U.S. Food and Drug Administration has approved an ...
GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
Alcon ALC recently announced the U.S. introduction of its Clareon Toric intraocular lens (IOL) at the upcoming American Academy of Ophthalmology (AAO) 2022 annual meeting in Chicago. With this, the ...
Novartis' ($NVS) Alcon received FDA approval for its implantable AcrySof IQ ReSTOR +2.5 Diopter intraocular lens (IOL), enabling vision correction at all distances in ...
Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...
Alcon Inc. ALC has been gaining from strength across the Surgical and Vision Care franchises. The company’s focus on research and innovation is also encouraging. The stock currently carries a Zacks ...
Alcon also has a suite of eyecare products under the Systane (dry eye relief) and Pataday (ocular allergy relief) brands. We expect the segment to grow in the midsingle digits over our forecast period ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results